
UMP Healthcare Holdings Limited
0722.HKHKSEHealthcareMedical - Care Facilities
Latest quote
HK$0.45
HK$0.00 · 0.00%
0722.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteUMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solution Services and Clinical Healthcare Services. Its extensive service portfolio encompasses virtual medical support, general family practice, and specialized consultations covering diverse fields like internal medicine, surgery, pediatrics, cardiology, dermatology, ENT, orthopedics, ophthalmology, urology, gastroenterology, endocrinology, and diabetes. Additionally, it provides comprehensive dental services, including implants, cosmetic procedures, periodontal care, and orthodontics, alongside traditional Chinese medicine. The company further extends its offerings to include physiotherapy, addressing muscle strengthening, limb and hand function, and eye-hand coordination. Other key services feature day surgery and endoscopy, advanced diagnostic imaging and laboratory testing, health assessments, visa-required medical examinations, immunization and advisory services, vision correction and optometry, reconstructive and aesthetic surgeries (plastic, head, and neck), dermatological and cosmetic treatments, ongoing chronic disease management, and COVID-19 screening. Furthermore, UMP Healthcare is involved in delivering training and advisory services within the healthcare sector. Its client base includes insurance providers, corporate clients, and individual self-paying patients. The organization maintains a vast network of roughly 1,100 directly owned and partnered service facilities. Established in 1990, UMP Healthcare Holdings Limited has its main offices situated in Central, Hong Kong.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- Headquarters
- HK
- CEO
- Cheuk Kwan Kwok
- Listed since
- Nov 27, 2015
- Employees
- 452
Market position
52-week range
Current HK$0.45
- Open
- HK$0.45
- Previous close
- HK$0.45
- Volume
- 26K
- 0.45× average
- Average volume
- 58.29K
- Average daily volume
- Market cap
- 364.93M HKD
- Beta
- 0.33
- Market reference 1
- 50-day average
- HK$0.4495
- +0.11% above average
- 200-day average
- HK$0.4642
- -3.06% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 237.9M HKD
- P/E (TTM)
- 11×
- P/B (TTM)
- 0.47×
- P/S (TTM)
- 0.5×
- EV / EBITDA
- 2.96×
- Earnings yield
- 8.29%
- Free cash flow yield
- 35.28%
- Dividend yield
- 7.33%
Profitability & efficiency
- Gross margin
- 67.75%
- Operating margin
- 29.89%
- Net margin
- 4.41%
- Return on equity
- 4.23%
- Return on assets
- 2.87%
- Return on invested capital
- 18.40%
Financial health
- Debt / equity
- 0.15×
- Current ratio
- 1.99×
- Altman Z-score
- 2.78
- Piotroski F-score
- 8 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (HKD) | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 727.36M HKD | 748.49M HKD | 727.75M HKD | 666.2M HKD | 617.16M HKD |
| Cost of goods sold | 236.75M HKD | 56.24M HKD | 225.06M HKD | 202.25M HKD | 160.89M HKD |
| Gross profit | 490.61M HKD | 692.25M HKD | 502.69M HKD | 463.95M HKD | 456.28M HKD |
| Selling, general, and administrative | 272.38M HKD | 269.4M HKD | 269.44M HKD | 249.11M HKD | 227.77M HKD |
| Operating expenses | 272.38M HKD | 287.54M HKD | 269.44M HKD | 249.11M HKD | 227.77M HKD |
| Interest income | 5.01M HKD | 5.54M HKD | 3.39M HKD | 1.35M HKD | 3.28M HKD |
| Interest expense | 7.35M HKD | 6.94M HKD | 5.68M HKD | 3.92M HKD | 3.22M HKD |
| Depreciation and amortization | 42.75M HKD | 113.79M HKD | 103.89M HKD | 78.62M HKD | 76.87M HKD |
| Operating income | 218.23M HKD | 95.4M HKD | 66.77M HKD | 81.75M HKD | 104.41M HKD |
| Net income | 31.44M HKD | 40.64M HKD | 60.45M HKD | 72.17M HKD | 34.83M HKD |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 0.02
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.033
2025 complete year-13.2% since 2021
2026 partial: HK$0.014
HK$0.038
2,021
HK$0.045
2,022
HK$0.047
2,023
HK$0.033
2,024
HK$0.033
2,025
HK$0.014
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Mar 16, 2026 | HK$0.014Semi-Annual | Mar 18, 2026 | Apr 15, 2026 |
Dividend | Dec 9, 2025 | HK$0.019Semi-Annual | Dec 11, 2025 | Jan 9, 2026 |
Dividend | Mar 17, 2025 | HK$0.014Semi-Annual | Mar 19, 2025 | Apr 11, 2025 |
Dividend | Dec 10, 2024 | HK$0.02Semi-Annual | Dec 12, 2024 | Jan 10, 2025 |
Dividend | Mar 18, 2024 | HK$0.013Semi-Annual | Mar 20, 2024 | Apr 19, 2024 |
Dividend | Dec 5, 2023 | HK$0.03Semi-Annual | Dec 7, 2023 | Jan 5, 2024 |
Ex-dividend Mar 16, 2026
HK$0.014
Semi-Annual
Record Mar 18, 2026 · Payment Apr 15, 2026
Ex-dividend Dec 9, 2025
HK$0.019
Semi-Annual
Record Dec 11, 2025 · Payment Jan 9, 2026
Ex-dividend Mar 17, 2025
HK$0.014
Semi-Annual
Record Mar 19, 2025 · Payment Apr 11, 2025
Ex-dividend Dec 10, 2024
HK$0.02
Semi-Annual
Record Dec 12, 2024 · Payment Jan 10, 2025
Ex-dividend Mar 18, 2024
HK$0.013
Semi-Annual
Record Mar 20, 2024 · Payment Apr 19, 2024
Ex-dividend Dec 5, 2023
HK$0.03
Semi-Annual
Record Dec 7, 2023 · Payment Jan 5, 2024
0722.HK peers
Continue in GoAI
Research 0722.HKresearch.disclaimer





